Samsrita Labs Ltd
Samsrita Labs Ltd Share Price Today: Live Updates & Key Insights
Get insights on Samsrita Labs Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Samsrita Labs Ltd Share Price Chart
SAMSRITALABS at 10 Jul 2026 05:49 PM Healthcare Services
13.45 +0.63(+4.91%)
Lowest Today 12.51
Highest Today 13.46
Today's Open 13.44
Prev. Close 12.82
52 Week High 26.04
52 Week Low 11.20
Samsrita Labs Ltd Fundamentals
Traded Volume: 42,677
Market Cap(Cr): 30.60
Avg Traded Price 13.28
1 Year return -30.74%
Upper Circuit 13.5
Lower Circuit 12.5
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) 5.74
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Samsrita Labs Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Samsrita Labs Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Samsrita Labs Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -30.74%
YTD 0.00%
Samsrita Labs Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Samsrita Labs Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Samsrita Labs Ltd Technical Details
Samsrita Labs Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 13
Support 2 12
Support 3 12
Pivot Point : 13
Resistance 1 14
Resistance 2 14
Resistance 3 14
Samsrita Labs Ltd Corporate Actions
Samsrita Labs Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Samsrita Labs Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by SAMSRITALABS
Bonus
No Bonus has been declared by SAMSRITALABS
Splits
No Split has been declared by SAMSRITALABS
Others
Rights No Rights has been declared by SAMSRITALABS
Samsrita Labs Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Samsrita Labs Ltd with leading peers in the healthcare sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Samsrita Labs Ltd's relative performance and valuation against major competitors.
Stock Name Bandaram Pharma Packtech Ltd ₹24.78 (+8.07%) M. Cap (Cr) 0.45 1 Yr Return (%) -38.31% P/E (TTM) 121.41 PB Ratio 1.56
Stock Name Sharma East India Hosp and Medical Research Ltd ₹105.47 (-2.30%) M. Cap (Cr) 0.35 1 Yr Return (%) +36.21% P/E (TTM) 26.54 PB Ratio 2.57
Stock Name GKB Ophthalmics Ltd ₹60.00 (-1.61%) M. Cap (Cr) 0.30 1 Yr Return (%) -19.03% P/E (TTM) 24.82 PB Ratio 0.57
Stock Name Samsrita Labs Ltd ₹13.45 (+4.91%) M. Cap (Cr) 0.31 1 Yr Return (%) -30.74% P/E (TTM) -3.42 PB Ratio 2.62
Stock Name Deccan Health Care Ltd ₹13.39 (+0.68%) M. Cap (Cr) 0.33 1 Yr Return (%) -36.18% P/E (TTM) 12.19 PB Ratio 0.28
Stock Name Transgene Biotek Ltd ₹3.08 (0.00%) M. Cap (Cr) 0.23 1 Yr Return (%) -37.65% P/E (TTM) -14.12 PB Ratio 2.79
Stock Name Vanta Bioscience Ltd ₹25.29 (+4.98%) M. Cap (Cr) 0.18 1 Yr Return (%) -4.24% P/E (TTM) 166.08 PB Ratio 0.85
Samsrita Labs Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Samsrita Labs Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -5.02 Mar 2025 -0.23 Mar 2024 -0.13 Mar 2023 0.66 Mar 2022 -0.40
PARTICULARS Investing Activities Mar 2026 3.26 Mar 2025 0.00 Mar 2024 0.00 Mar 2023 0.00 Mar 2022 0.00
PARTICULARS Financing Activities Mar 2026 3.39 Mar 2025 0.22 Mar 2024 0.13 Mar 2023 -0.67 Mar 2022 0.40
PARTICULARS Net Cash Flow Mar 2026 1.63 Mar 2025 0.00 Mar 2024 0.00 Mar 2023 0.00 Mar 2022 0.01
Samsrita Labs Ltd Shareholding Pattern
This shows the ownership breakdown of Samsrita Labs Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Samsrita Labs Ltd
Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996. The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022. Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own. The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also.In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.; Nutraceuticals product development; Trading, exporting and importing of medicinal drugs, chemicals, re-agents etc.In 2016-17, the Company entered into a Collaborative Agreement with Krisani Bio Sciences Private Limited for further development of NASH (Fatty Liver) Molecule and Wilson Disease Molecule on revenue sharing basis and also entered into a Collaborative Agreement with Centre For liver Research And Diagnostics (CLRD) to use their land , building, equipment and other facilities to run their business of Hospital, Diagnostics, Pharmacy, Stem cell and other bio-technology laboratories on revenue sharing basis. A diversified healthcare company with innovation is at the forefront of research and development in stem cells & regenerative medicine, new drug discovery, RNAi therapeutics, biomarker discovery. The Company was named after late Dr.CM Habeebullah, whose dedication and passion form the backbone of the Company's core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi Specialty Hospital and CRO.Krisani Bio Sciences Private Limited ceased to be the subsidiary of the Company with effect from 12.11.2021 and was made an Associate Company because of allotment of 64,00,000 equity shares at Rs. 10/- each by Krisani Bio Sciences Private Limited, erstwhile Subsidiary of the Company on a preferential basis and as a result the shareholding of the Company in Krisani Bio Sciences Private Limited came down from 51.33% to 32.91% in 2022.During year 2024-25, the Board of Directors in the meeting held on 30.04.2025, altered the objects of the company by adding a new sub-clause including engaging in biofuels, food industry including processing, seeds, Green technologies, Information technology including deep technologies, logistics, e-commerce, Clinical research and allied activities and advisory services.
Chairman & Exec. Director
K Krishnam Raju
Registered office Sy No 36 Chintalmet X Roads, Upperpally Attapur Rajendra Ng, Hyderabad, Telangana, 500048
FAX :91-90300 57370
Background
Incorporation Year 1996
Face Value ₹10.00
Market Lot 1
FAQs on Samsrita Labs Ltd
How to buy Samsrita Labs Ltd shares?
To buy Samsrita Labs Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Samsrita Labs Ltd?
The company has a market capitalization of ₹30.60.
What is the PE & PB ratio of Samsrita Labs Ltd?
PE is N/A and PB is N/A.
What is the Samsrita Labs Ltd dividend for 2025–26?
For the 2025–26 financial year, Samsrita Labs Ltd declared a final dividend of null% per share.